Johnson & Johnson Moves Toward Sale of DePuy Synthes, Potential Price Tag Exceeds $20 Billion
Johnson & Johnson is preparing to market its orthopedics unit, DePuy Synthes, assembling documents and financial information ahead of meetings with potential buyers in the coming weeks. The business, which posted $9.3 billion in sales last year, could command a valuation above $20 billion and is drawing interest from private equity consortia as wel…